A Study to Evaluate Safety and Efficacy of TTP273 for 12 Weeks in Subjects With Type 2 Diabetes
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 174 participants.
Also called NCT02653599
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 174 participants
- Sponsor
- Registry
-
NCT02653599
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02653599. Randomized; double masking; primary purpose treatment. Start 2015-12 (registry gives no type); primary completion 2016-11 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Evaluate Safety and Efficacy of TTP273 for 12 Weeks in Subjects With Type 2 Diabetes
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- TTP273
- Intervention (Drug)
- Placebo
- Lead sponsor
- vTv Therapeutics
Record details
- Record id
cardio:ct-nct02653599- Content hash
683aad15b595af89782c1289182d7a326ab67aec93061f4efc8c67cd8b32d393